Instituto: INSTITUTO DE BIOLOGIA MOLECULAR Y CELULAR DEL CANCER DE SALAMANCA

DISSECTING THE TGF-BETA SIGNALLING PATHWAY IN SEARCH OF NEW AND BETTER THERAPEUTIC TARGETS FOR CHOLANGIOCARCINOMA